Prognostic significance of lymph node ratio after resection of peri-hilar cholangiocarcinoma

HPB

Volumn 13, Issue 4, 2011, Pages 240-245

  Guglielmi, Alfredo ^a   Ruzzenente, Andrea ^a   Campagnaro, Tommaso ^a   Pachera, Silvia ^a   Conci, Simone ^a   Valdegamberi, Alessandro ^a   Sandri, Marco ^b   Iacono, Calogero ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

Author keywords

cholangiocarcinoma; prognostic factors; surgery

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER SURVIVAL; CONTROLLED STUDY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; RETROSPECTIVE STUDY;

EID: 79952917526     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2010.00277.x     Document Type: Article

References (22)

1. Patel T,. (2002) Worldwide trends in mortality from biliary tract malignancies. BMC Cancer 2: 10.
2. Nakeeb A, Pitt HA, Sohn TA, Coleman J, Abrams RA, Piantadosi S, et al,. (1996) Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 224: 463-473; discussion 473-465.
3. Guglielmi A, Ruzzenente A, Campagnaro T, Pachera S, Valdegamberi A, Capelli P, et al,. (2010) Does intrahepatic cholangiocarcinoma have better prognosis compared to perihilar cholangiocarcinoma? J Surg Oncol 101: 111-115.
4. Launois B, Terblanche J, Lakehal M, Catheline JM, Bardaxoglou E, Landen S, et al,. (1999) Proximal bile duct cancer: high resectability rate and 5-year survival. Ann Surg 230: 266-275. (Pubitemid 30191894)
5. Nagakawa T, Kayahara M, Ikeda S, Futakawa S, Kakita A, Kawarada H, et al,. (2002) Biliary tract cancer treatment: results from the Biliary Tract Cancer Statistics Registry in Japan. J Hepatobiliary Pancreat Surg 9: 569-575. (Pubitemid 36305102)
6. Lai EC, Lau WY,. (2005) Aggressive surgical resection for hilar cholangiocarcinoma. ANZ J Surg 75: 981-985. (Pubitemid 43934432)
7. Nishio H, Nagino M, Oda K, Ebata T, Arai T, Nimura Y., (2005) TNM classification for perihilar cholangiocarcinoma: comparison between 5th and 6th editions of the AJCC/UICC staging system. Langenbecks Arch Surg 390: 319-327. (Pubitemid 41110976)
8. Young AL, Prasad KR, Toogood GJ, Lodge JP,. (2009) Surgical treatment of hilar cholangiocarcinoma in a new era: comparison among leading Eastern and Western centers, Leeds. J Hepatobiliary Pancreat Surg.
9. Bando E, Yonemura Y, Taniguchi K, Fushida S, Fujimura T, Miwa K., (2002) Outcome of ratio of lymph node metastasis in gastric carcinoma. Ann Surg Oncol 9: 775-784.
10. Pawlik TM, Gleisner AL, Cameron JL, Winter JM, Assumpcao L, Lillemoe KD, et al,. (2007) Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. Surgery 141: 610-618. (Pubitemid 46616937)
11. Lee HY, Choi HJ, Park KJ, Shin JS, Kwon HC, Roh MS, et al,. (2007) Prognostic significance of metastatic lymph node ratio in node-positive colon carcinoma. Ann Surg Oncol 14: 1712-1717.
12. Tamandl D, Kaczirek K, Gruenberger B, Koelblinger C, Maresch J, Jakesz R, et al,. (2009) Lymph node ratio after curative surgery for intrahepatic cholangiocarcinoma. Br J Surg 96: 919-925.
13. Strasberg SM,. (2005) Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system. J Hepatobiliary Pancreat Surg 12: 351-355. (Pubitemid 41662443)
14. Liver Cancer Study Group of Japan. (2003) General Rules for Clinical and Pathological Study of Primary Liver Cancer, 2nd English edn. Tokyo: Kanehara.
15. Igami T, Nishio H, Ebata T, et al,. (2009) Surgical treatment of hilar cholangiocarcinoma in the 'new era': the Nagoya University experience. J Hepatobiliary Pancreat Surg 17: 449-454.
16. Neuhaus P, Jonas S, Bechstein WO, Lohmann R, Radke C, Kling N, et al,. (1999) Extended resections for hilar cholangiocarcinoma. Ann Surg 230: 808-818; discussion 819.
17. Kitagawa Y, Nagino M, Kamiya J, Uesaka K, Sano T, Yamamoto H, et al,. (2001) Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection. Ann Surg 233: 385-392. (Pubitemid 32187818)
18. Iwatsuki S, Todo S, Marsh JW, Madariaga JR, Lee RG, Dvorchik I, et al,. (1998) Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation. J Am Coll Surg 187: 358-364. (Pubitemid 28467610)
19. Ogura Y, Kawarada Y,. (1998) Surgical strategies for carcinoma of the hepatic duct confluence. Br J Surg 85: 20-24. (Pubitemid 28034104)
20. Edge SB, Compton CC, Fritz AG, Greene FL, Trotti A,. (2010) AJCC Cancer Staging Handbook. New York, NY: Springer.
21. Ito K, Ito H, Allen PJ, Gonen M, Klimstra D, D'Angelica MI, et al,. (2010) Adequate lymph node assessment for extrahepatic bile duct adenocarcinoma. Ann Surg 251: 675-681.
22. Schwarz RE, Smith DD,. (2007) Lymph node dissection impact on staging and survival of extrahepatic cholangiocarcinomas, based on U.S. population data. J Gastrointest Surg 11: 158-165.